Christopher D. Corso

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Parker L. Sulkowski, Christopher D. Corso, Nathaniel D. Robinson et al. · Science Translational Medicine · 2017 · 564 citations

Medicine, Cancer Biology, Oncology +17

Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair

Parker L. Sulkowski, Ranjini K. Sundaram, Sebastian Oeck et al. · Nature Genetics · 2018 · 215 citations

Life Sciences, Genetics, Molecular Biology +14

Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer

Elyn H. Wang, Christopher D. Corso, Charles E. Rutter et al. · Journal of Clinical Oncology · 2015 · 107 citations

Medicine, Oncology, Surgery +17

Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database

Christopher D. Corso, Charles E. Rutter, Lynn D. Wilson et al. · Journal of Thoracic Oncology · 2014 · 104 citations

Medicine, Oncology, Radiation Oncology +15

Trends in stereotactic body radiation therapy for stage I small cell lung cancer

John M. Stahl, Christopher D. Corso, Vivek Verma et al. · Lung Cancer · 2016 · 101 citations

Medicine, Oncology, Radiation Oncology +14